FDA OKs Second Gene Therapy for Hemophilia B

(MedPage Today) -- The FDA has approved a second gene therapy for adults with hemophilia B, drugmaker Pfizer announced on Friday. The approval of fidanacogene elaparvovec (Beqvez) stipulates use in adult men with moderate to severe hemophilia...
Source: MedPage Today Public Health - Category: American Health Source Type: news